EU orders biotech giant Illumina to unwind $7.1 billion purchase of cancer-screening company Grail
By RAF CASERT Associated Press BRUSSELS (AP) — The European Union is ordering U.S. biotech giant Illumina to undo its $7.1 billion purchase of…
Continue Reading